Ilhan-Mutlu, Aysegül http://orcid.org/0000-0001-8291-0873
Wöll, Ewald
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 4 September 2023
Accepted: 8 October 2023
First Online: 19 October 2023
Conflict of interest
: A. Ilhan-Mutlu declares following potential conflict of interests: participation in advisory boards organized by MSD, Servier, Daiichi Sankyo, BMS and Astellas, lecture honoraria from Eli Lilly, Servier, BMS, MSD, Astellas and Daiichi Sankyo, consulting for Astellas, MSD, Amgen and Astra Zeneca, travel support from BMS, Roche, Eli Lilly and Daiichi Sankyo. E. Wöll declares following potential conflict of interests: lecture honoraria and advisory roles for Astellas Pharma, Astra Zeneca, BMS, Calgen, Daiichi Sankyo, Ebewe, Eisai, Eli Lilly, Elsevier, Janssen Cilag, Merck, MSD, Novartis, Pierre Fabre, Pfizer, Ratiopharm, Roche, Sanofi Aventis, Servier, Takeda.